baber/WOPTO huggingface dataset:
Patent DE-69517335-T2 (DE)
Inventor: MORINIGO B
IPC: F01L9/20
Filed: 1995-11-09
Granted: 2001-01-04
Abstract: An electromagnetically actuated valve is disclosed. The valve includes an upper electromagnetic element and a lower electromagnetic element in a mirrored and facing relationship to each other. The electromagnetic elements define a central channel that surrounds a vertical axis. The valve further includes an armature element that is disposed intermediate the upper and lower electromagnets. The armature element is pivotally mounted to an armature shaft. The armature shaft is perpendicular to the vertical axis. The valve further includes a coil disposed within the central channel of each of the electromagnetic elements.
Patent DE-69532409-T2 (DE)
Inventor: HAEMAELAEINEN JARI
IPC: H04Q11/04
Filed: 1995-01-20
Granted: 2004-12-02
Abstract: PCT No. PCT/FI95/00024 Sec. 371 Date Jul. 16, 1996 Sec. 102(e) Date Jul. 16, 1996 PCT Filed Jan. 20, 1995 PCT Pub. No. WO95/20283 PCT Pub. Date Jul. 27, 1995For packet data transmission between fixed network elements, such as a mobile exchange, a base station controller and base stations, in a mobile communication system, a node-to-node packet data transmission in a digital mobile communication network is carried out by using network elements as packet nodes and by utilizing existing signalling protocols between them for transmitting data packets. Only a processing of incoming and outgoing data packets is introduced into the network elements. The normal signalling messages of a mobile communication network used for packet data transmission are only provided with a new identifier indicating that the message contains packet data, so that the packet data messages can be forwarded to the packet data processing, instead of normal signalling message handling.
Patent DE-69601869-T2 (DE)
Inventor: LABEYRIE ANTONIE
IPC: H01S5/042
Filed: 1996-05-23
Granted: 1999-10-14
Abstract: PCT No. PCT/FR96/00775 Sec. 371 Date Nov. 24, 1997 Sec. 102(e) Date Nov. 24, 1997 PCT Filed May 23, 1996 PCT Pub. No. WO96/37933 PCT Pub. Date Nov. 28, 1996In a transmission laser feeding an optical fibre to which it is coupled, the method comprises providing a Lippmann effect structure with thin stratifications by injecting into the laser light-guide a series of individual modulating electrical currents, applied via a photoemissive medium (12) to a plurality of discrete electrodes (1-6) regularly spaced along the path of the transmitted laser beam (18), so that the optical fibre carries a light spectrum corresponding to the Fourier transform of the set of data input by said modulating currents as electrical signals.
Patent DE-69603954-T2 (DE)
Inventor: PEDERSEN TORBEN
IPC: G07F7/08
Filed: 1996-05-10
Granted: 2000-01-27
Abstract: The invention relates to a method for protected payment with electronic payment device, such as "intelligent" payment cards ("smart cards"), in a variable number of steps. In this connection, use is made of a non-reversible function, of which successive function values are provided by the payment device to the payment station in question by way of proof of payment. On the basis of these function values, there may take place both a verification and a determination of the number of steps. Such method finds application, e.g., in public telephones and in copiers. The invention further relates to a payment device and a payment system for applying the method.
Patent DE-69607184-T2 (DE)
Inventor: FIORANI ALBERTO
IPC: E04H6/40
Filed: 1996-09-10
Granted: 2001-03-22
Abstract: This invention concerns a roto-translating trolley for garaging cars. The trolley according to the invention consists of a centre platform (17) to which two bridge runners (18) are fixed. Said platform (17) rotates freely about a vertical pin (15a) projecting from an element (2) which slides along a track (1) fixed to the garage floor.
Patent DE-69622882-T2 (DE)
Inventor: FREDRIKSSON LARS
IPC: F16G17/00
Filed: 1996-12-16
Granted: 2002-12-19
Abstract: A coupling device for coupling a hoisting member, such as a hook (1), to a flexible hoisting strap (7). The device includes a coupling part (4) having a straight bar portion (6) with which the strap (7) engages. The device also includes a hoisting body part, such as a hook body (2) to be coupled to a hoisting device or a load. An entrance opening (10) is located opposite to the straight bar portion (6) and is dimensioned to snugly receive the narrowest dimension of the hoisting strap (7).
Patent DE-69623079-T2 (DE)
Inventor: MARRON GUY
IPC: B60B21/12
Filed: 1996-06-17
Granted: 2004-04-08
Abstract: The automobile wheel (1) comprises a central circular web (2), a cylindrical rim (3) composed of a rear (4) and front (5) cylindrical parts. The rim parts are separated by the web plane which extends perpendicularly to the rim axis (6). A steel sound insulating ring (11) placed concentric with the rim has a layer of visco-elastic material and is mechanically coupled to the rim. This coupling ensures the ring is hooped onto the cylindrical parts of the rim. The ring has an omega shaped transverse section and has two circular support edges ensuring contact with the rim parts.
Patent DE-69626643-T2 (DE)
Inventor: DAVENPORT M
IPC: A61M16/06
Filed: 1996-06-03
Granted: 2004-01-29
Abstract: A pneumatically-operated gas demand apparatus coupled in interruptible fluid communication between a recipient and a first source of a pressurized first gas controls delivery of the first gas to the recipient as the recipient inhales and exhales and comprises a supply valve and a sensing valve. The supply valve has a first interior chamber divided by a flexible first diaphragm into a supply chamber region and a control chamber region. The supply chamber region is in interruptible fluid communication between the first source of the first gas and the recipient. The control chamber region is in continuous fluid communication with a second source of a pressurized second gas. The sensing valve has a second interior chamber divided by a flexible second diaphragm into a venting chamber region and a sensing chamber region. The venting chamber region is in interruptible fluid communication between the control chamber region and an ambient air environment. The sensing chamber region is in continuous fluid communication with the recipient. When the recipient inhales, the second diaphragm moves to a flow-causing position to cause the second gas to flow into the ambient air environment and causes the first diaphragm to move to a flow-supplying position thereby delivering the first gas to the recipient. When the recipient exhales, the second diaphragm moves to a flow-stopping position to prevent the second gas to flow into the ambient air environment and causes the first diaphragm to move to a flow-blocking position thereby preventing delivery of the first gas to the recipient.
Patent DE-69628410-T2 (DE)
Inventor: MCCLINTIC FRANK J
IPC: G09B9/12
Filed: 1996-02-05
Granted: 2004-03-18
Abstract: A flight simulator wherein the pitch, roll and yaw axes are separated from the trainee to provide a more realistic simulated flight experience in that the trainee feels a translation as well as a rotation of his body as he performs a simulated climb, turn, or roll.
Patent DE-69631656-T2 (DE)
Inventor: CHIPMAN STEWART
IPC: C07D487/04
Filed: 1996-06-05
Granted: 2004-12-16
Abstract: Disclosed is a method of treating osteoarthritis. The method comprises administering a therapeutic amount of debromohymenialdisine to an individual or animal with osteoarthritis. Debromohymenialdisine is able to slow the joint deterioration and cartilage degradation associated with the disease.
Patent DE-69633412-T2 (DE)
Inventor: SCHUTZ MARTIJN ARNOUD
IPC: F16H55/56
Filed: 1996-11-18
Granted: 2005-02-17
Abstract: The invention relates to a pulley, in particular for a continuously variable transmission. The pulley is provided with at least two discs (30,34) on a pulley shaft (38) and/or a sleeve (39) of the pulley shaft (38). At least one disc (34) is axially displaceable by means of operating means (43-46). The pulley is of modular construction. In particular, the operating means (43-46) can comprise a piston/cylinder assembly (43,44;45,46) with a cylinder (43) individually fixed to the disc (34). <IMAGE>
Patent DE-69636951-T2 (DE)
Inventor: HOWARD ALAN NORMAN WHITE
IPC: A23L33/00
Filed: 1996-06-07
Granted: 2007-11-22
Abstract: The carotenoids lutein and zeaxanthin are used either separately or in combination to treat age-related macular degeneration (AMD). The carotenoids are administered in the form of a pharmaceutical preparation, e.g. a capsule or alternatively as a food e.g. a genetically engineered tomato producing enhanced levels of carotenoid. High dosages of lutein and zeaxanthin are needed to ensure high serum levels necessary for take up of the carotenoids by the macula.
Patent DE-69637332-T2 (DE)
Inventor: WILLIAMS LEWIS T
IPC: A61P17/02
Filed: 1996-09-27
Granted: 2008-10-09
Abstract: The invention provides a therapeutical composition for epithelial wound repair that is a combination of PDGF and KGF. Further, the invention provides a composition for epithelial wound repair that is a therapeutic combination of PDGF, KGF and IGF. Additionally, the invention provides a therapeutic composition of PDGF, KGF, IGF and IGFBP for epithelial wound repair
Patent DE-69701038-T2 (DE)
Inventor: MARTIN PHILIPPE
IPC: G06K19/00
Filed: 1997-04-30
Granted: 2000-10-12
Abstract: A thin integrated circuit card with an improved manually activated switch. The card is of the type that has two external plates, a lower one (12) and an upper one (14) that are separated by at least one interconnecting plate in which there is at least one switch (26). The switch is able to allow or inhibit the passage of an electric current between its two terminals (34). The switch has a pushbutton (28) which is positioned at a peripheral edge (40) of the card.
Patent DE-69711024-T2 (DE)
Inventor: HANNSON HANS-ARNE
IPC: A61L31/04
Filed: 1997-01-16
Granted: 2002-09-19
Abstract: There is provided the use of a thrombin inhibitor in the manufacture of a product for use in the control of wound healing processes within the body, in particular, the inhibition or prevention of fibrin-related adhesion and/or scar tissue formation, as well as products for use in the control of wound healing processes within the body comprising polysaccharides (e.g., chitosans) and low molecular weight peptide-based thrombin inhibitors.
Patent DE-69728259-T2 (DE)
Inventor: SLATER B
IPC: H01L23/31
Filed: 1997-04-14
Granted: 2004-08-26
Abstract: A monollithic CMOS integrated device formed in silicon carbide and method of fabricating same. The CMOS integrated device includes a layer of silicon carbide of a first conductivity type with a well region of a second conductivity type formed in the layer of silicon carbide. A MOS field effect transistor is formed in the well region and a complementary MOS field effect transistor is formed in the silicon carbide layer. The method of fabrication of CMOS silicon carbide includes formation of an opposite conductivity well region in a silicon carbide layer by ion implantation. Source and drain contacts are also formed by selective ion implantation in the silicon carbide layer and the well region. A gate dielectric layer is formed by deposition and reoxidation. A gate electrode is formed on the gate dielectric such that a channel region is formed between the source and the drain when a bias is applied to the gate electrode. Source drain and body contacts are preferably formed of the same material in a single fabrication step.
Patent DE-69729314-T2 (DE)
Inventor: SHIMIZU YASUHIKO
IPC: A61L31/04
Filed: 1997-11-19
Granted: 2005-07-07
Abstract: The present invention relates to an ultra-fine fibrous collagen obtainable by freezing a1N hydrochloric acid solution of collagen at about -10 to -196 DEG C for at least about 6 hours followed by freeze-drying the frozen collagen solution in a vacuum.
Patent DE-69730476-T2 (DE)
Inventor: TSUBOTA KAZUO
IPC: A61K38/00
Filed: 1997-04-17
Granted: 2005-11-17
Abstract: The present invention provides a pharmaceutical composition for treatment of corneal and conjunctival lesion, and dry eye comprising albumin as an active ingredient. The pharmaceutical composition is also useful for increase of eye surface epithelium mucin secretion. The present invention further provides a method for treatment of corneal and conjunctival lesion, and dry eye, which comprises administering, to a subject in need of such treatment, albumin in an amount effective. In addition, the present invention provides a use of albumin for manufacture of a pharmaceutical composition of the present invention.
Patent DE-69733621-T2 (DE)
Inventor: SEABROOK RONALD H
IPC: D03D13/00
Filed: 1997-03-04
Granted: 2006-05-04
Abstract: A composite forming fabric in which the woven paper and machine side layers are interconnected by pairs of intrinsic weft binder yarns (A,B) which interweave with the paper side layer to occupy an unbroken weft path. Each member interweaves sequentially with the warps of the paper side layer (1-8) and with at least one warp of the machine side layer (11-18). Each part of the unbroken weft path is separated from adjacent parts by at least one paper side layer warp yarn. The unbroken weft path is the same, or different, to the weft path of the immediately adjacent paper side layer weft yarns (W). This arrangement overcomes the paper side layer surface imperfections, which cause an unacceptable level of marking, hitherto associated with the use of intrinsic weft binder yarns in composite fabrics. <IMAGE>
Patent DE-69735883-T2 (DE)
Inventor: GOLDSPINK GEOFFREY
IPC: A61K38/30
Filed: 1997-03-11
Granted: 2007-04-19
Abstract: An IGF-I polypeptide or functional derivative thereof characterized by the presence of the Ec peptide or functional equivalent thereof for use in a method of treatment or therapy of the human or animal body.
Patent DE-69818639-T2 (DE)
Inventor: KIM HEE-CHUL
IPC: C12Q1/56
Filed: 1998-06-16
Granted: 2004-08-05
Abstract: The present invention relates to a method of determining the enzymatic activity of blood coagulation factor XIII by using purified fibrin monomer as a substrate of this enzyme. The enzymatic activity is determined by detecting the degree of cross-linking of fibrin monomer formed by the blood coagulation factor XIII and the fibrin monomer free of blood coagulation factor XIII is obtained by washing the preparation with citric acid solution. The present method can be effectively used for the validation of the other enzymatic assay methods for the blood coagulation factor XIII as well as the studies for the characterization of the blood coagulation factor XIII.
Patent DE-69820473-T2 (DE)
Inventor: LEE FURN LI
IPC: A47B46/00
Filed: 1998-10-03
Granted: 2004-10-07
Abstract: A storage system for sheeted objects such as clothes, including a storage unit, formed of a first component and a second component, and a rail assembly which includes a main rail and an extension portion in the form of at least one pivotally or telescopically connected rail element. The element is adapted to be supported in an extended condition, externally of the first component, so as to increase the effective length of the rail assembly when the second component is in an open condition.
Patent DE-69820634-T2 (DE)
Inventor: BOUCHARD HERVE
IPC: C07D405/14
Filed: 1998-07-15
Granted: 2004-10-21
Abstract: Provided herein are novel polyhydroxyalkylpyrazine derivatives useful in treating and preventing a plethora of diseases including diabetes, having a general formula ofwherein Rc1 represents the chain (II) -CH(OR4)CH(OR3)CH(OR2)CH2OR1 and either Rc2 represents a hydrogen atom and either Rc3 represents the chain (III)-CH2CH(OR6)CH(OR7)CH2OR8 or Rc2 represents the chain (IV)-CH(OR5)CH(OR6)CH(OR7)CH2OR8 or chain (III) -CH2CH(OR6)CH(OR7)CH2OR8 and Rc3 represents a hydrogen atom, and 1 to 8 substituents R1, R2, R3, R4, R5, R6, R7, R8, identical or different, represent a radical independently selected among the radicals a) -COR9, b) -COOR10, c) -CR11R12OCOR13, d) -CR11R12OR13, e) -CONR14R15, and f) one or more pairs of the substituents R1, R2, R3, R4, R6, R7, R8, consecutive or separated by one of the other substituents R2, R3, R6, R7 can also form a group: -C(O)-; the other substituents R1, R2, R3, R4, R6, R7, R8 are hydrogen atoms.
Patent DE-69829891-T2 (DE)
Inventor: BACA MANUEL
IPC: C12N15/02
Filed: 1998-04-03
Granted: 2005-10-06
Abstract: Humanized and variant anti-VEGF antibodies and various uses therefore are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells  in vitro,  and inhobit tumor growth  in vitro.
Patent DE-69830335-T2 (DE)
Inventor: DENNEY LYLE
IPC: A61P29/00
Filed: 1998-10-26
Granted: 2006-02-02
Abstract: The compound, ((3(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2-methyl-1H-indol-4-yl)oxy)acetic acid morpholino-ethyl ester, is disclosed together with its use as a highly bioavailable indole compound for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
Patent DE-69836279-T2 (DE)
Inventor: KOHNO HIROAKI
IPC: C07D405/04
Filed: 1998-08-19
Granted: 2007-05-31
Abstract: A novel in vivo compound 2-amino-3-Ä2-( alpha -mannopyranosyl)indol-3-ylÜpropionic acid; a method for inspecting the function of the living body, characterized by quantitatively determining 2-amino-3-Ä2-( alpha -mannopyranosyl)indol-3-ylÜpropionic acid in a harvested living body sample and judging the function of the living body from the determined value; an antibody which specifically reacts with 2-amino-3-Ä2-( alpha -mannopyranosyl)indol-3-ylÜpropionic acid; a hybridoma which produces the antibody; a method for immunologically assaying 2-amino-3-Ä2-( alpha -mannopyranosyl)indol-3-ylÜpropionic acid, characterized by immunologically assaying 2-amino-3-Ä2-( alpha -mannopyranosyl)indol-3-ylÜpropionic acid in a sample with the antibody; and a process for preparing 2-amino-3-Ä2-( alpha -mannopyranosyl)indol-3-ylÜpropionic acid derivatives. <IMAGE>
Patent DE-69836358-T2 (DE)
Inventor: CANFIELD DAVID LEE
IPC: B65H19/18
Filed: 1998-07-20
Granted: 2007-10-11
Abstract: An improved method for bonding webs. The method includes overlapping two webs, slitting the two webs (10,11), reoverlapping the two webs and bonding the two webs (10,11) together. The steps of reoverlapping the two webs may be accomplished with a number of different types of devices including but not limited to : a bumpered roll (12), a notched roll, a crowned roll, a bowed roll and out of plane roll, and variable speeds rolls. <IMAGE>
Patent DE-69836638-T2 (DE)
Inventor: GREENE I
IPC: C07K7/64
Filed: 1998-05-29
Granted: 2007-10-04
Abstract: The present invention relates to peptides and peptide analogues designed from a binding loop of a member of the tumor necrosis factor receptor (TNF-R) superfamily. In particular, it relates to cyclic peptides and peptide analogues designed from a binding loop of TNF-R which inhibit TNF binding to its cellular receptors, and methods of making and using such compounds to inhibit the biological activities of TNF.
Patent DE-69837331-T2 (DE)
Inventor: DOLL RONALD J
IPC: A61P35/00
Filed: 1998-06-15
Granted: 2007-11-15
Abstract: Compounds of the following formula useful for inhibiting Ras function and therefore inhibiting or treating the abnormal growth of cells are disclosed: or an N-oxide thereof, or a pharmaceutically acceptable salt or solvate thereof, wherein: R and R2 are halo; R1 and R3 are H and halo, provided that at least one of R1 and R3 is H; X is N, CH or C, when the double bond is present at the C-11 position; R4 is=O, -NHOH, -N=NHR6, -N=NHSO2R6, -N=NHCOR6, -N=NHCONH2, -N=NHCOCONH2, (H, OH), (H, -OR6), (H, -OCOR6), (H, OSO2R6) or -E-(CH2)n1-G-, wherein n1 is 1 to 5, and E and G are O, S or N, and are joined to the same carbon to form a cyclic structure; R5 is H, lower alkyl, or optionally substituted aryl, heteroaryl, aralkyl, heteroaralkyl or heterocycloalkyl-alkyl; R6 is lower alkyl or optionally substituted aryl, heteroaryl, aralkyl, heteroaralkyl or heterocycloalkyl-alkyl; R7, R8 and R9 are independently selected from the group consisting of H, lower alkyl, aryl, and aralkyl; and n is 0-5.
Patent DE-69920007-T2 (DE)
Inventor: MARZI MAURO
IPC: C07C227/02
Filed: 1999-05-18
Granted: 2005-09-15
Abstract: A process is described for the stereoselective synthesis of R-(-)-carnitine in which the characterizing step is condensation of glycerol with an amine of (-)camphorsulfonic acid.
Patent DE-69920417-T2 (DE)
Inventor: TALISH ROGER
IPC: G10K11/00
Filed: 1999-03-17
Granted: 2006-02-23
Abstract: An apparatus and method for mounting an ultrasound transducer head module. The apparatus includes an insert having an axial bore therein and a plurality of tabs extending radially therefrom. A spacer is provided and configured to fit within a void in a cast. The spacer has a hole therein to insertably receive the insert. An ultrasound transmission-enhancing medium is positioned within the hole in the spacer and adjacent a treatment location. The ultrasound treatment head module is then positioned within the insert and means for biasing it toward the ultrasound transmission-enhancing medium is provided. A strap may be provided to secure the apparatus adjacent a body portion to be treated, with or without the existence of a cast.
Patent DE-69921804-T2 (DE)
Inventor: BROWN SUTHERLAND
IPC: C07C237/40
Filed: 1999-05-11
Granted: 2005-10-27
Abstract: The invention concerns amide derivatives of Formula (I) wherein: R1 and R2 include hydroxy, C1-6alkoxy, mercapto, C1-6akylthio, amino and heterocyclyl; m and p are independently 0-3; R3 is halo, cyano or C1-6alkoxy; q is 0-4; and R4 is aryl or cycloalkyl wherein R4 is optionally substituted with up to 3 substituents having any value defined for each R1 group; or a pharmaceutically-acceptable salt or in-vivo-cleavable ester thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
Patent DE-69926383-T2 (DE)
Inventor: EVANS PAUL ANDREW
IPC: H04L12/46
Filed: 1999-09-17
Granted: 2006-04-27
Abstract: A packet network is arranged into a hierarchy, having one organization-level portion (CS, P, R 2 ) and three site-level portions (S 1 , S 2 , S 3 ). By using forwarding computers and assigning multicast addresses in respect of each portion, the total number of multicast addresses required to send multicast messages to all possible subsets of potential recipients is reduced. This alleviates routers in the network of the burden associated with storing and processing a large amount of multicast addresses.
Patent DE-69932086-T2 (DE)
Inventor: GHETZLER RICHARD
IPC: F01D25/12
Filed: 1999-12-14
Granted: 2007-01-25
Abstract: A low drag ducted ram air turbine generator and cooling system is provided. The ducted ram air turbine generator and cooling system has reduced drag while extracting dynamic energy from the air stream during the complete range of intended flight operating regimes. A centerbody/valve tube having an aerodynamically shaped nose is slidably received in a fairing and primary structure to provide a variable inlet area. An internal nozzle control mechanism attached to the valve tube positions nozzle control doors to provide variable area nozzles directing air flow to the turbine stator and rotor blades to maintain optimum generator efficiency. An alternate embodiment includes an annular internal nozzle having interleaved panels to modulate the air flow to the turbine.